Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizOn labeling someone an expert in intellectual property
By Lawrence B. Ebert, Esq.
What caught the eye of IPBiz was the following text:
USC Professor Jonathan Aronson, an expert in intellectual property, said Vakay's column constituted plagiarism - despite the fact Wolfram had given her permission to use his ideas.
"In my view, it is improper what she did," Aronson said, adding it would have been a non-issue if she would have merely mentioned the source of the ideas.
"Is it actionable?" he said. "Nobody's going to sue her about it. She should be embarrassed by it."
As IPBiz has noted before, plagiarism and copyright infringement are two different things, with only the latter actionable under Federal law. The presence of permission in this case would seem to remove the issue of copyright infringement. And, noboby COULD SUE for plagiarism. As to issues under trademark law concerning false designation of source, perhaps Aronson needs to review the Dastar case.
Of the credentials of Jonathan D. Aronson:
A.B. Harvard University, 1971
Ph.D. Stanford University, 1976
Fellowships Council on Foreign Relations
European Community?s Visitor?s Program
Annenberg School of Communication and
School of International Relations.
IPBiz has a query to Brandon Lowrey, the author of the story mentioned above. What makes Professor Aronson an expert in intellectual property?
Full post as published by IPBiz on December 19, 2009 (boomark / email).
Nanotechnology Law
Intellectual property laws
Compellent, Storage Engine, et. al.
$10.5 million settlement reached in intellectual property dispute.
General Electric Co. and SABIC Innovative Plastics
$3 million settlement reached in intellectual property dispute.
Darvocet
FDA Expert Panel Votes for Ban
Pull Vicodin, Percocet
Expert Panel Advises FDA
Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports
Transdermal Drug Patches
Risk of Burns Missing From Some Labeling

Intellectual Property And Access Can Co-Exist, US Rightsholders Say
No trade secret : Jorda in the Hall of Fame
UNCITRAL Lays Groundwork For Policy On IP Assets And Financing
Canadian Study Calls for New IP
The Use of Rhetoric When Discussing Intellectual Property Law
Experts Aim To Balance Intellectual Property Rights And Human Rights








